Gubin, Poland

Daniel Sulikowski



Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Daniel Sulikowski: Innovator in Pharmaceutical Chemistry**

Introduction

Daniel Sulikowski is a distinguished inventor based in Gubin, Poland, with a remarkable portfolio of five patents. His work primarily focuses on the development of innovative compounds that have significant implications in the field of medicine, particularly in relation to their roles as ligands of the PPAR-gamma receptor.

Latest Patents

Among his latest patents, Daniel has developed novel 3-phenylpropionic acid derivatives. These compounds are defined by their chemical formula, where W represents either a COOH group or its bioisosters, or a COO—C-C-alkyl group. The properties of these compounds hold potential therapeutic applications, particularly for diseases mediated by the peroxysome proliferator-activated receptor gamma (PPAR-γ). His inventions encompass not only the compounds themselves but also methods for their therapeutic use, advocating for administration in varying amounts to achieve effective treatment or prophylaxis for individuals in need.

Career Highlights

Throughout his career, Daniel has made significant contributions to pharmaceutical chemistry. His innovative approach to compound development has led to several critical patents that advance medical treatment options. Working at Adamed Sp. z o.o., he has been able to translate his inventive ideas into practical applications, fostering advancements in healthcare.

Collaborations

Daniel's inventive journey is further enriched by his collaborations with esteemed colleagues including Zbigniew Majka and Katarzyna Ewa Rusin. These partnerships in the research and development process underscore the importance of teamwork in driving innovation within the pharmaceutical sector.

Conclusion

In conclusion, Daniel Sulikowski exemplifies the impact of innovation in the pharmaceutical industry through his patents and collaborative efforts. His work not only contributes to the field of medicinal chemistry but also promises to enhance treatment options for various medical conditions. As he continues to innovate, the future looks promising for the advancements stemming from his research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…